Winton Group LTD Celldex Therapeutics, Inc. Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$20.5 - $37.33 $170,601 - $310,660	8,322 New	8,322 $224,000
Q4 2020 Feb 12, 2021	SELL	$14.99 - $22.75 $362,458 - $550,095	-24,180 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$9.65 - $15.19 $46,117 - $72,593	4,779 Added 24.63%	24,180 $359,000
Q2 2020 Aug 05, 2020	BUY	$1.61 - $13.41 $11,872 - $98,885	7,374 Added 61.31%	19,401 $252,000
Q1 2020 May 11, 2020	SELL	$1.55 - $3.07 $31,000 - $61,400	-20,000 Reduced 62.45%	12,027 $20,000
Q4 2019 Feb 13, 2020	SELL	$2.11 - $2.8 $3,447 - $4,575	-1,634 Reduced 4.85%	32,027 $71,000
Q3 2019 Nov 08, 2019	BUY	$2.05 - $2.75 $69,005 - $92,567	33,661 New	33,661 $72,000

194

64.9M

1.65M

973K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.04B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.